NFA
NVAX icon

Nationwide Fund Advisors’s Novavax NVAX Stock Holding History

Nationwide Fund Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,816
Closed -$178K – 1404
2017
Q3 		$178K Sell
7,816
-43,385
-85% -$971K ﹤0.01% 2688
2017
Q2 		$1.18M Buy
51,201
+43,385
+555% +$851K ﹤0.01% 1698
2017
Q1 		$200K Sell
7,816
-528
-6% -$14.5K ﹤0.01% 2586
2016
Q4 		$210K Sell
8,344
-4,103
-33% -$120K ﹤0.01% 2579
2016
Q3 		$518K Buy
12,447
+283
+2% +$36.5K ﹤0.01% 2166
2016
Q2 		$1.77M Buy
12,164
+131
+1% +$15K 0.01% 1420
2016
Q1 		$1.26M Buy
12,033
+503
+4% +$54K 0.01% 1583
2015
Q4 		$1.94M Sell
11,530
-11,712
-50% -$1.8M 0.01% 1376
2015
Q3 		$3.29M Sell
23,242
-6,793
-23% -$1.52M 0.01% 1126
2015
Q2 		$6.69M Sell
30,035
-5,137
-15% -$903K 0.03% 806
2015
Q1 		$5.82M Sell
35,172
-3,648
-9% -$592K 0.02% 904
2014
Q4 		$4.6M Sell
38,820
-577
-1% -$60.3K 0.02% 985
2014
Q3 		$3.29M Buy
39,397
+11,427
+41% +$1.03M 0.01% 1172
2014
Q2 		$2.58M Buy
27,970
+7,224
+35% +$635K 0.01% 1340
2014
Q1 		$1.88M Buy
20,746
+13,560
+189% +$1.51M 0.01% 1400
2013
Q4 		$736K Buy
7,186
+1,806
+34% +$128K ﹤0.01% 2041
2013
Q3 		$340K Buy
5,380
+355
+7% +$20K ﹤0.01% 2403
2013
Q2 		$206K Buy
+5,025
New +$218K ﹤0.01% 2474

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nationwide Fund Advisors's NVAX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Novavax (NVAX) in Q4 2017, closing a stake of 7,816 shares — an estimated $178K sold.

Nationwide Fund Advisors first reported a position in NVAX in Q2 2013 and held it in 18 quarters. The position peaked at $6.69M in Q2 2015. 134 funds tracked by Wall St. Rank hold NVAX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Novavax position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 7,816 Novavax shares in Q4 2017, an estimated $178K.
  • Nationwide Fund Advisors first reported a position in Novavax in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Novavax position peaked at $6.69M in Q2 2015.
  • 134 funds tracked by Wall St. Rank held Novavax as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.